GCF Programme definition

GCF Programme means a programme comprising several projects, activities and/or investments for which a Funding Proposal has been approved by the Board;
Sample 1Sample 2Sample 3

Examples of GCF Programme in a sentence

  • Monitor budgets and continuously maintain up-to-date financial records for the account of the GCF Programme, of allotments and expenditures under each budget line, prepare regular financial reports, including annual reports.

  • The GCF Programme will increase their resilience to climate change impacts.NGOs, civil society, church groups, island disaster committeesCivil society organisations will benefit from opportunities to expand work they already do with communities, build on successful pilot projects and to extend the range of their activities.

  • Note: If an alternative to paper copies of SDSs is used, describe the format and how employees can access them.When revised SDSs are received, the following procedures will be followed to replace old SDSs: Old SDS will be placed into an obsolete file and not discarded.

  • At this point, the GCF Programme team will move into the delivery phase of migration from GCF to the new service.

  • Mukasyan, Current Opinion in Solid State and Materials Science, 2008,12, 44- 50.

  • The Project also benefits from regular consultative meetings on the GCF Programme Portfolio, as organized by Viet Nam’s NDA annually as part of the GCF readiness project.

  • The five countries involved in the GCF Project “Enhancing Climate Information and Knowledge Services for resilience in 5 island countries of the Pacific Ocean” (Tuvalu, Niue, Marshall Islands, Palau and Cook Islands) have been confirmed as pilots for the GBON initiative through this GCF Programme.

Related to GCF Programme

  • CRAF Program means the Civil Reserve Air Fleet Program authorized under 10 U.S.C. Section 9511 et seq. or any similar or substitute program under the laws of the United States.

  • Programme means any television broadcast and includes-

  • the Programme means the Government programme for delivery of smart metering in Great Britain. The Programme is responsible for overseeing the development and implementation of policy, including establishing the commercial and regulatory framework to facilitate the roll-out;

  • Maintenance Programme shall have the meaning set forth in Clause 14.3; “Maintenance Period” shall have the meaning set forth in Clause 14.1; “Maintenance Requirements” shall have the meaning set forth in Clause 14.2;

  • Video programmer means a person or entity that provides video programming to end-user

  • Collaborative pharmacy practice agreement means a written and signed

  • AML Program has the meaning ascribed thereto in Schedule 2.1(F)(8) hereof.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Marketing program means a program established by order of the director pursuant to this act prescribing rules and regulations governing the marketing for processing, distributing, selling, or handling an agricultural commodity produced in this state or agricultural commodity input during a specified period and

  • WOSB Program Repository means a secure, Web-based application that collects, stores, and disseminates documents to the contracting community and SBA, which verify the eligibility of a business concern for a contract to be awarded under the WOSB Program.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Electronic Programme Guide or “EPG” means a program guide maintained by the IPTV Operator that lists television channels and programmes, and scheduling and programming information therein and includes any enhanced guide that allows subscribers to navigate and select such available channels and programmes.

  • Programme Date means the date of this Base Prospectus.

  • Government Apprenticeship Programme “ means training which is funded by the Government via the National Apprenticeship Service.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Video programming means programming provided by, or generally considered comparable to programming provided by, a television broadcast station.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Collaborative pharmacy practice means a practice of pharmacy whereby one or

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Programme Document means the formal document (in standard format) attached to this Agreement, which is concluded by the Parties and reflects expected results, detailed activities, timeframes and budget, and defines what is to be accomplished. The Programme Document is the basis for requisitioning, committing and disbursing funds to carry out planned activities and for their monitoring and reporting.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.